Prostate Cancer - Results from #28660

Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer - Abstract February 14, 2011

ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program - Abstract February 14, 2011

Initial biopsy outcome prediction in Korean patients-comparison of a noble web-based Korean prostate cancer risk calculator versus prostate-specific antigen testing - Abstract February 14, 2011

The health and well-being of prostate cancer patients and male-to-female transsexuals on androgen deprivation therapy: A qualitative study with comments on expectations and estrogen - Abstract February 14, 2011

Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer - Abstract February 11, 2011

How to improve the surgery of prostate cancer? - Abstract February 11, 2011

Intimacy-enhancing psychological intervention for men diagnosed with prostate cancer and their partners: A pilot study - Abstract February 11, 2011

Contemporary therapeutic approaches targeting bone complications in prostate cancer - Abstract February 11, 2011

Improving outcomes with recent advances in chemotherapy for castrate-resistant prostate cancer - Abstract February 11, 2011

The current and emerging role of immunotherapy in prostate cancer - Abstract February 11, 2011

Prediction of pathological outcomes for a single microfocal (≤ 3 mm) Gleason 6 prostate cancer detected via contemporary multicore (≥12) biopsy in men with prostate-specific antigen ≤ 10 ng/mL - Abstract February 11, 2011

iProstate, a mathematical predictive model-based, 3D-rendering tool to visualize the location and extent of prostate cancer - Abstract February 10, 2011

Genome-wide linkage scan for prostate cancer susceptibility in Finland: Evidence for a novel locus on 2q37.2 and confirmation of signal on 17q21-q22 - Abstract February 10, 2011

Physical activity and survival after prostate cancer diagnosis in the Health Professionals Follow-Up Study - Abstract February 10, 2011

Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy - Abstract February 10, 2011

Associations of circulating and dietary vitamin D with prostate cancer risk: A systematic review and dose-response meta-analysis - Abstract February 10, 2011

Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: Improved staging or increased morbidity? - Abstract February 10, 2011

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: Recommendations from a European Consensus Meeting - Abstract February 10, 2011

Sweeping view of prostate cancer genome yields deep insights February 10, 2011

When should we expect no residual tumor (pT0) once we submit incidental T1a-b prostate cancers to radical prostatectomy? - Abstract February 9, 2011

Page 1434 of 1438